RTW Investments logo

RTW Investments

Crunchbase
Crunchbase

Deals on record

8

Common Fundraising Type

Series A

Windward Bio logo
Windward Bio

Drug development

Novo Holdings logo
OrbiMed logo
RTW Investments logo
Qiming Venture Partners logo
Quan Capital logo
Pivotal bioVenture Partners logo
Omega Funds logo
SR One logo

Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.

Series A
$200M
01/10/2025
Article

Numab Therapeutics is a biotech company that develops multi-specific antibody-based immunotherapies for inflammation and cancer.

Series C
$55M
01/10/2025
Article
Alesta Therapeutics logo
Alesta Therapeutics

Biotechnology

Frazier Life Sciences logo
Thuja Capital logo
SSI Strategy logo
RTW Investments logo
RV Invest logo
Novartis logo
Droia Ventures logo

Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Series A
$67.4M
01/08/2025
Article
Beta Bionics logo
Beta Bionics

Medical Technology

Wellington Management logo
RTW Investments logo
Soleus Capital logo
Sands Capital logo
Perceptive Advisors logo
Omega Funds logo
Marshall Wace logo
Eventide Asset Management logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series E
$60M
11/15/2024
Article
Evommune logo
Evommune

Biotechnology

RA Capital Management logo
Verition Fund Management logo
Symbiosis logo
RTW Investments logo
Sectoral Asset Management logo
Pivotal bioVenture Partners logo
NEXTBio Capital logo
Marshall Wace logo

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Series C
$115M
10/31/2024
Article
Kailera Therapeutics logo
Kailera Therapeutics

Biopharmaceutical

RTW Investments logo
Lyra Capital logo
Bain Capital Life Sciences logo
Atlas Venture logo

Kailera Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and related metabolic conditions.

Series A
$400M
10/07/2024
Article
Aktis Oncology logo
Aktis Oncology

Biotechnology

RA Capital Management logo
RTW Investments logo
Janus Henderson Investors logo
T. Rowe Price Associates logo
MRL Ventures Fund logo
Eli Lilly and Company logo
Bristol Myers Squibb logo
Avidity Partners logo

Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.

Series B
$175M
09/30/2024
Article
Beta Bionics logo
Beta Bionics

Medical Technology

Soleus Capital logo
Sands Capital logo
RTW Investments logo
Pura Vida Investments logo
Perceptive Advisors logo
Omega Funds logo
Marshall Wace logo
Farallon Capital logo

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Series D
$100M
09/01/2023
Article